Cognitive Decline Slowed With Cognitive Remediation in At-Risk Adults
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- For older adults at risk for cognitive decline, especially those with remitted major depressive disorder (rMDD), with or without mild cognitive impairment (MCI), cognitive remediation (CR) plus transcranial direct current stimulation (tDCS) is effective for slowing cognitive decline, according to a study published online Oct. 30 in JAMA Psychiatry.
Tarek K. Rajji, M.D., from the Campbell Family Mental Health Research Institute in Toronto, and colleagues examined the efficacy of CR plus tDCS targeting the prefrontal cortex in older adults with rMDD, MCI, or both. A total of 486 older adults provided consent; 375 received at least one intervention session.
The researchers found that CR and tDCS slowed cognitive decline in older adults with rMDD or MCI during a median follow-up of 48.3 months (adjusted z score difference at month 60, 0.21; 95 percent confidence interval, 0.07 to 0.35). CR and tDCS did not improve cognition acutely in the preplanned primary analysis (adjusted z score difference at month 2, 0.06; 95 percent confidence interval, −0.006 to 0.12). There was a weak and not significant effect seen for CR and tDCS on delaying progression from normal cognition to MCI or from MCI to dementia (hazard ratio, 0.66; 95 percent confidence interval, 0.40 to 1.08). Treatment effects were seen for executive function and verbal memory in preplanned analyses; interactions were seen with diagnosis and APOE ε4, indicating a larger effect for those with rMMD and for APOE ε4 noncarriers.
"Our trial demonstrated the efficacy of a combined therapy of CR and tDCS in slowing cognitive decline in a high-risk sample," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.